Sathish Parasuraman - Concepedia

Author

Sathish Parasuraman

Also Known As

N. Kyriakakis, S Parasuraman, S. Parasuraman, Sathish K Parasuraman, Sathish K. Parasuraman, Sathish Kumar Parasuraman, Sathish Parasuraman, Satish K. Parasuraman, Satish Kumar Parasuraman

Publications

482

Citations

H-Index

Concepts

All Affiliations

University of Aberdeen University of East Anglia Aberdeen Royal Infirmary Musgrove Park Hospital Royal Brompton Hospital

About

Sathish Parasuraman is an author at University of Aberdeen specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	71
2	Health Sciences	1	1	27
3	Public Health	1	1	34
4	Emergency Medicine	1	1	34
5	Exercise Physiology	1	1	34

Sathish Parasuraman

Publications

142

Citations

H-Index

Page 1

	Year	Citations
Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction Sathish Parasuraman, Brodie Loudon, Crystal Lowery, Journal of the American Heart Association HypertensionHeart FailurePulmonary HypertensionCardiovascular FunctionDiastolic Function	2019	34
Inorganic Nitrate in Angina Study: A Randomized Double‐Blind Placebo‐Controlled Trial Konstantin Schwarz, Satnam Singh, Sathish Parasuraman, Journal of the American Heart Association	2017	27
Safety, tolerability, and pharmacokinetics of TAK-701, a humanized anti-hepatocyte growth factor (HGF) monoclonal antibody, in patients with advanced nonhematologic malignancies: First-in-human phase I dose-escalation study. Suzanne F. Jones, Richard B. Cohen, J. C. Bendell, Journal of Clinical Oncology ImmunologyPathologyMetronomic ChemotherapyTumor BiologyFree Serum Hgf	2010	27
Prevalence of asymptomatic valvular heart disease in the elderly population: a community-based echocardiographic study Vasiliki Tsampasian, Cristian Militaru, Sathish Parasuraman, European Heart Journal - Cardiovascular Imaging	2024	19
Smoking status and mortality outcomes following percutaneous coronary intervention Sathish Parasuraman, Azfar Zaman, Mohaned Egred, European Journal of Preventive Cardiology	2020	14
The unspoken benefit of participation in a clinical trial Konstantin Schwarz, Sathish Parasuraman, Satnam Singh, Clinical Medicine	2021	11
Bortezomib, bendamustine, and rituximab in patients (pts) with relapsed (rel) or refractory (ref) follicular lymphoma (FL): Dose-finding results of the VERTICAL study J. Matouš, Jeffrey Letzer, Peter J. Rosen, Journal of Clinical Oncology ImmunologyPathologyVertical StudyPharmacotherapyImmunotherapy	2009	10

Page 1